1. Introduction {#sec1-nutrients-09-00069}
===============

Metabolic acidosis is a common complication of chronic kidney disease (CKD) when the glomerular filtration rate falls below 30--40 mL/min/1.73 m^2^ \[[@B1-nutrients-09-00069],[@B2-nutrients-09-00069],[@B3-nutrients-09-00069]\]. Current guidelines recommend treatment with alkali when bicarbonate levels are lower than 22 mMol/L \[[@B1-nutrients-09-00069]\] to prevent complications, such as insulin resistance \[[@B4-nutrients-09-00069],[@B5-nutrients-09-00069]\], cardiovascular diseases and progression of CKD, among others \[[@B6-nutrients-09-00069],[@B7-nutrients-09-00069]\].

A correction of metabolic acidosis can be achieved with pharmacological administration of oral alkali as sodium bicarbonate, but also with a diet rich of fruit and vegetables \[[@B8-nutrients-09-00069],[@B9-nutrients-09-00069],[@B10-nutrients-09-00069]\]. In addition, conservative therapy of CKD with low-protein content diets has been revised and reached the scientific rigor of nutritional therapy with the purpose of obtaining a reduction of sodium intake and hypertension \[[@B11-nutrients-09-00069],[@B12-nutrients-09-00069]\], of phosphate intake and serum phosphate levels \[[@B13-nutrients-09-00069],[@B14-nutrients-09-00069]\], of proteinuria \[[@B15-nutrients-09-00069],[@B16-nutrients-09-00069]\], and a delay of dialysis initiation \[[@B17-nutrients-09-00069]\], through a reduced load of catabolites and a better metabolic control \[[@B17-nutrients-09-00069],[@B18-nutrients-09-00069],[@B19-nutrients-09-00069]\]. Hence, as fruit and plant proteins are able to reduce dietetic acid load \[[@B20-nutrients-09-00069],[@B21-nutrients-09-00069],[@B22-nutrients-09-00069]\], our aim is to evaluate whether a very low-protein diet (VLPD) reduces both the acid load in patients with CKD and the need of administrating oral sodium bicarbonate.

2. Materials and Methods {#sec2-nutrients-09-00069}
========================

We conducted a case-control study in 146 patients participating in the UBI study---a multicentric, prospective, cohort, randomized, open-label and controlled study, registered in ClinicalTrials.gov (NCT01640119), in which patients were randomized to receive either oral sodium bicarbonate or placebo, in order to evaluate mortality and dialysis risk or doubling of creatinine levels \[[@B23-nutrients-09-00069]\]. All 146 patients were chosen from the experimental arm of the UBI study; therefore, they were all administered oral bicarbonate: 54 out of them assumed a VLPD and 92 case-controls assumed a control diet together with oral bicarbonate. The duration of follow-up was 12 months. We excluded diabetic subjects to avoid bias due to glycemic control complications. [Figure 1](#nutrients-09-00069-f001){ref-type="fig"} shows the study-flow diagram. Seventy-four subjects assuming VLPD encountered study criteria; 7 of them were excluded because of incompleteness of urinary data needed to calculate protein intake, and 13 because of lack of corresponding controls. Finally, among the included patients (54), only 38 of them had a case-control ratio of 1:2, while the other 16 subjects had a 1:1 ratio.

VLPD consisted of a vegetarian, high-energy diet, with a protein content of 0.3--0.4 g/Kg body weight (BW)/day supplemented with amino-acids and ketoacids in tablets (AlfaKappa^®^ Fresenius Kabi, Verona, Italia). The main nutritional differences between VLPD and control group diet were plant and animal proteins amount, phosphate and salt content (see [Table 1](#nutrients-09-00069-t001){ref-type="table"}).

During the course of CKD several metabolic alterations appear (hyperazotemia, metabolic acidosis, hyperpotassiemia, hyperphosphatemia, increase of parathyroid hormone (PTH) levels, intestinal dysbiosis), that are all positively influenced by a nutritional therapy using a VLPD. This diet is characterized by low-protein content with supplements of essential amino-acids and ketoanalogues (proteins used are roughly 90% of plant type), low phosphate content (300--450 mg in VLPD versus 1000--1200 mg in an usual diet), low salt content (80--95 mmol/day in VLPD versus 140--180 mmol/day in a usual diet), and low organic acids and saturated fats amount. The effects of VLPD in terms of reduction or normalization of urea levels in CKD are excellent, but the effects on other biochemical parameters are also worthy of interest \[[@B25-nutrients-09-00069]\].

Every 6 months, study participants performed the common biochemical blood tests and urine parameters (24 h urine urea, creatinine, phosphate, potassium, natrium and protein levels). Particular attention was paid to a correct 24 h urine collection, and all patients were trained in detail how to perform a correct procedure.

Actual protein intake was evaluated according to the formula of Maroni et al.: daily protein intake (g/day) = (6.25 × urinary urea nitrogen mg/day) + (0.031 × body weight-kg) + urinary proteins g/day \[[@B26-nutrients-09-00069]\], using 24-h urinary urea and not dietetic interviews. Twenty-four hour urinary urea excretion together with urinary potassium and phosphate excretion were used to calculate the potential renal acid load (PRAL) and net endogenous acid production (NEAP) every 3 months. PRAL and NEAP, both inversely correlated with serum bicarbonate levels, represent the non-volatile acid load derived from nutrition, estimated by the production of non-volatile acids and bases produced during digestion based on known nutritional content \[[@B27-nutrients-09-00069]\]. PRAL was calculated by the following formula as described by Remer and Manz \[[@B28-nutrients-09-00069]\]: calculated PRAL (mEq/day) = (0.49 × protein intake, g/day) + (0.037 × phosphorus intake, mmol/day) − (0.021 × potassium intake, mmol/day) − ( 0.026 × magnesium, mmol/day) − (0.013 × calcium, mmol/day); NEAP was calculated by the formula described by Frassetto et al. \[[@B29-nutrients-09-00069]\]: NEAP (mEq/day) = (54.5 × protein intake (g/day)/potassium intake, (mmol/day)) − 10.2. Thus, protein intake contained in the two previous formulas was calculated with Maroni formula \[[@B26-nutrients-09-00069]\], and phosphorus and potassium intake were estimated from 24-h urinary phosphate and potassium excretion, representing the actual phosphate and potassium daily intake, in metabolic stable patients.

Finally, the amount of oral bicarbonate needed to maintain bicarbonate plasma levels between 24 and 28 mEq/L was evaluated every 3 months.

3. Statistical Analysis {#sec3-nutrients-09-00069}
=======================

Data were reported as mean ± SD or counts (percentage), when appropriate. Un-paired *T*-test and Chi-square test were used to assess differences between study groups at baseline and study completion. Two-tailed probability values ≤0.05 were considered statistically significant. Analyses were completed using R version 3.1.3 (9 March 2015) (The R Foundation for Statistical Computing).

4. Results {#sec4-nutrients-09-00069}
==========

In VLPD group, the causes of renal disease were hypertensive-vascular nephropathies in 38% of patients, glomerulonephrites in 20%, tubule-interstitial nephropathies in 15%, unknown causes in 27% of patients; in control group the percentages were similar: 41%, 18%, 16%, and 24%, respectively. Moreover, the frequency of cardiovascular complications (angina, infarct, ictus) was 46% in VLPD group, and 42% in control group (*p* = NS).

[Table 2](#nutrients-09-00069-t002){ref-type="table"} shows the differences between VLPD and control diet at baseline.

Age and percentage of male sex were not different between the two groups because of the case-control design of the study. On the other hand, VLPD patients had a lower body weight (71.6 ± 13.1 vs. 77.8 ± 14.2 kg; *p* \< 0.0001). The other biochemical parameters were not different except for urinary creatinine (69.8 ± 29.1 in VLPD vs. 99 ± 32.7 µmol/day in control group; *p* \< 0.0001), as consequence of different body weights and residual renal function in the two groups (26 ± 12 mL/min in VLPD group vs. 39 ± 14 mL/min in control group; *p* \< 0.0001). There were no statistical differences between the two groups regarding systolic blood pressure (SBP), diastolic blood pressure (DBP), protein and phosphate intake, urinary natrium, potassium, phosphate and urea nitrogen, NEAP, and PRAL ([Table 2](#nutrients-09-00069-t002){ref-type="table"}).

[Table 3](#nutrients-09-00069-t003){ref-type="table"} shows differences at 6 and 12 months of the same parameters seen in [Table 2](#nutrients-09-00069-t002){ref-type="table"}. VLPD patients showed at 6 and also 12 months a significant reduction of SBP (*p* \< 0.0001), DBP (*p* \< 0.001), plasma urea (*p* \< 0.0001) protein intake (*p* \< 0.0001), calcemia (*p* \< 0.0001), phosphatemia (*p* \< 0.0001), phosphate intake (*p* \< 0.0001), urinary natrium (*p* \< 0.0001), urinary potassium (*p* \< 0.002), and urinary phosphate (*p* \< 0.0001). At six months potassemia was higher in VLPD group than in controls (*p* \< 0.001), but not at 12 months (patients were not administrated potassium binders, and the correction of hyperpotassemia at 12 months was mostly as a consequence of a physiological correction of metabolic acidosis).

As shown in [Figure 2](#nutrients-09-00069-f002){ref-type="fig"}, in the first six months the dose of oral bicarbonate administered was 0.86 ± 0.31 (controls) versus 0.51 ± 0.33 mmol/kg/day (VLPD group) (*p* \< 0.0001), while in the second part of follow-up it was 0.91 ± 0.42 (controls) versus 0.48 ± 0.35 mmol/kg/day (VLPD group) (*p* \< 0.0001).

Total oral bicarbonate administered in the first half of follow-up was 11,919 ± 297 mmol in controls and 6426 ± 224 mmol in VLPD patients, while in the second half of follow-up it was 12,448 ± 451 in controls and 5962 ± 374 mmol in VLPD patients ([Figure 2](#nutrients-09-00069-f002){ref-type="fig"}).

Therefore, during the follow-up VLPD reduced the amount of oral bicarbonate of 30--37 mEq/day. ([Table 3](#nutrients-09-00069-t003){ref-type="table"}).

In VLPD group, NEAP dropped from 71 ± 37 mEq/day to 33 ± 16 mEq/day (after six months) and to 25 ± 11 mEq/day (after 12 months) (*p* \< 0.001), while in control patients it remained unchanged (from 73 ± 35 mEq/day to 71 ± 39 mEq/day after six months and to 77 ± 41 mEq/day after 12 months (*p* = NS). Similarly, in VLPD patients PRAL reduced from 22 ± 9 mEq/day to −4.5 ± 4.1 mEq/day after six months and to −13 ± 6 mEq/day after 12 months (*p* \< 0.001). It was unchanged in control patients (24 ± 13 mEq/day vs. 22 ± 9 mEq/day vs. 34 ± 11 mEq/day respectively; *p* = NS). Therefore, in VLPD patients NEAP diminished of 53% after six months (*p* \< 0.0001) and of 67% after 12 months (*p* \< 0.0001); PRAL decreased of 120% after six months (*p* \< 0.0001) and of 138% after 12 months (*p* \< 0.0001).

5. Discussion {#sec5-nutrients-09-00069}
=============

Beneficial effects of a correction of metabolic acidosis has been described in several studies. In 2010, Menon showed in a post-hoc analysis of MDRD study that low plasma bicarbonate levels increased the risk of outcomes such as renal death and mortality \[[@B30-nutrients-09-00069]\]. Wesson et al. showed the paramount role of a diet rich in fruit and vegetables, not only from the nutritional point of view, but also in the nephrology field, because it ensures an amount of alkali that are needed in CKD \[[@B31-nutrients-09-00069],[@B32-nutrients-09-00069],[@B33-nutrients-09-00069],[@B34-nutrients-09-00069],[@B35-nutrients-09-00069],[@B36-nutrients-09-00069],[@B37-nutrients-09-00069],[@B38-nutrients-09-00069],[@B39-nutrients-09-00069],[@B40-nutrients-09-00069],[@B41-nutrients-09-00069]\].

The fact that the acid load linked to animal proteins is higher than that linked to plant proteins is already known in the scientific community \[[@B42-nutrients-09-00069],[@B43-nutrients-09-00069],[@B44-nutrients-09-00069]\]. Moe et al. showed that the use of only plant proteins, compared to animal proteins, was able to reduce daily serum and urinary phosphate levels in eight subjects, the load of sodium, calcium and phosphorus being equal \[[@B14-nutrients-09-00069]\]. Therefore, D'Alessandro et al.'s phosphorus pyramid seems useful as tool for dietary phosphate management \[[@B13-nutrients-09-00069]\]. Moreover, several studies showed that the use of animal proteins compared to fruit and plant proteins induced a worsening of hard outcomes such as mortality and CKD progression \[[@B39-nutrients-09-00069],[@B44-nutrients-09-00069]\]; then, nutritional therapy has to be deeply analyzed, and nutritional prescription has to be focused not only on reduction of protein content but also on proteins' quality \[[@B45-nutrients-09-00069]\].

Our study has some limitations: (1) it is a post-hoc analysis of a previous study, but with a case-control design that should reduce some bias; (2) the small number of patients (again, the case-control study has the property of amplifying the number of studied subjects); and (3) a follow-up of only 12 months.

A strength of our study is the direct measure of protein intake to calculate NEAP and PRAL with the Maroni formula based on 24-h urinary urea nitrogen instead of protein intake estimated by diary interviews, and direct measure of urinary phosphate and potassium. Our data showed that VLPD (containing high quantity of fruit and vegetables and with a very low-proteins amount supplemented with essential amino-acids and ketoanalogues of non-essential amino-acids) significantly reduced NEAP and PRAL. Essential amino-acids contained in VLPD respond to metabolic need ensuring a positive nitrogen balance, thus avoiding malnutrition, while ketoanalogues allow a significant reduction of serum urea levels using urea nitrogen to transform the ketoanalgous in the corresponding no-essential amino acid, as shown in our previous studies \[[@B46-nutrients-09-00069],[@B47-nutrients-09-00069]\].

The importance of serum urea reduction in CKD patients, somewhat neglected in recent decades, has now also been reconsidered because of its role in the etiopathogenesis of cyanate increase \[[@B47-nutrients-09-00069]\] and of intestinal microbial flora alteration in CKD patients \[[@B48-nutrients-09-00069]\]. Finally, a higher intake of fruit and vegetables with diet has not to be considered alarming in relation to hyperpotassiemia as long as patients have a good urine output because alkali introduction (contained in fruit and vegetables) facilitates intracellular potassium shift. Moreover, there was no difference in nutritional status before and after the study in the two groups. In fact, BMI did not change in both groups: 28 ± 4 kg/m^2^ and 27 ± 4 kg/m^2^ in VLPD group, and 30 ± 5 kg/m^2^ and 29 ± 4 kg/m^2^ in controls, before and after the study, respectively. Similarly, serum albumin was also unchanged: 38 ± 7 g/L and 38 ± 3 g/L in VLPD group, and 40 ± 5 g/L and 38 ± 3 g/L in controls, respectively.

In previous studies, VLPD produced a significant decrease of proteinuria, reducing phosphate burden and renal disease progression in CKD patients, also in patients treated with angiotensin converting enzyme-inhibitors, who did not achieve a satisfying proteinuria reduction with the drug \[[@B15-nutrients-09-00069]\]. The same happened in our subjects, who showed a proteinuria reduction from 424 mg to 11 mg/day after 12 months of follow-up.

Furthermore, several studies showed that VLPD reduces oxidative stress in both experimental animals \[[@B49-nutrients-09-00069],[@B50-nutrients-09-00069]\] and in humans \[[@B51-nutrients-09-00069]\].

We did not find any depressive symptoms in our patients nor in previous published studies.

It notable that the increase of creatinine clearance from 26 to 30 mL/min after 12 months (renal function gain of 4 mL/min in one year) together with an improvement of nutritional indexes in VLPD group compared to a reduction of creatinine clearance from 39 to 30 mL/min in one year in control group (renal function loss of 9 mL/min) is suggestive of the efficacy of VLPD as nutritional therapy.

In conclusion, nutritional therapy of CKD, which has always taken into consideration a lower protein, salt, and phosphate intake, should also be adopted to correct metabolic acidosis, an important target in the treatment of CKD patients. Correction of metabolic acidosis is not only the aim of VLPD, but also of a vegetarian diet \[[@B37-nutrients-09-00069],[@B38-nutrients-09-00069],[@B48-nutrients-09-00069],[@B52-nutrients-09-00069],[@B53-nutrients-09-00069]\].

We provide useful indications regarding acid load of food and drinks (see [Table 4](#nutrients-09-00069-t004){ref-type="table"}A--E) that may be used as an acid load dietary "traffic light" similar to the phosphorus pyramid of D'Alessandro et al. \[[@B13-nutrients-09-00069]\].

The green light indicates that food can be consumed every day, while the yellow light means a two or three times a week consumption, and the red light an occasional food consumption. Of course, when using the "traffic light" information, one must always consider that the phosphorus content in plant foods have a lower absorption than that contained in foods of animal origin \[[@B12-nutrients-09-00069],[@B14-nutrients-09-00069]\]; thus, animal foods with low phosphate content can lead to a higher acid load than vegetables with higher phosphate content, because of its higher intestinal absorption. Similarly, fear of potassium in fruits and vegetables in CKD is overrated, especially in CKD patients-4 and CKD-5 with retained urine flow. In fact, in these patients, hyperkalemia can be often determined by the use of aldosterone antagonists (especially for high doses) or, to a lesser degree, of inhibitors of the renin angiotensin aldosterone system drugs, or a combination of both \[[@B32-nutrients-09-00069],[@B33-nutrients-09-00069]\].

Finally, nutritional therapy of CKD should take into account not only a low-protein diet, but also a rational, complex and integrated control of sodium, phosphorus and acids intake with food \[[@B18-nutrients-09-00069],[@B52-nutrients-09-00069],[@B54-nutrients-09-00069]\]. This means that a reduced intake of proteins is not the only important determinant of nutritional therapy of CKD but also the quality of proteins assumed and the amount of calories (no less than 30--34 kilocalories/body weight/day) in order to maintain a good metabolic and nutritional status and avoid malnutrition \[[@B55-nutrients-09-00069],[@B56-nutrients-09-00069],[@B57-nutrients-09-00069]\].
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nutrients-09-00069-t001_Table 1

###### 

Diet's composition of the two groups.

                             Control      VLPD
  -------------------------- ------------ ------------
  Total Kilocalories         2320 ± 207   2110 ± 225
  Total protein (g/kg/day)   0.6--1       0.3--0.4
  Animal protein (%)         75           10
  Vegetal protein (%)        25           90
  Sodium range (mmol)        140--180     80--95
  Potassium range (mmol)     40--60       30--50
  Calcium range (mg)         1000--1200   500--750
  Phosphorus range (mg)      700--900     300--450
  Magnesium range (mg)       300--400     300--400

VLPD is a nutritional therapy used in advanced stages of CKD (from stage 3B to more severe stages) \[[@B24-nutrients-09-00069]\].

nutrients-09-00069-t002_Table 2

###### 

Patients' baseline data.

                                 All              Control          VLPD             *p*
  ------------------------------ ---------------- ---------------- ---------------- --------
  Number                         146              92               54               
  Males, %                       58               58               58               NS
  Age, years                     73.6 ± 11.2      73.7 ± 11.9      73.5 ± 10.0      NS
  Height, cm                     161 ± 8          162 ± 7          159 ± 8          NS
  BW, kg                         75.5 ± 14.1      77.8 ± 14.2      71.6 ± 13.1      0.0001
  SBP, mm Hg                     122 ± 20         125 ± 17         117 ± 23         NS
  DBP, mm Hg                     73 ± 9           74 ± 8           71 ± 10          NS
  Creatinine, µmol/L             187.41 ± 68.01   180.34 ± 65.42   198.02 ± 72.49   NS
  Azotemia, mmol/L               31.1 ± 11.4      31.4 ± 11.1      30.3 ± 12.1      NS
  Glycaemia, mmol/L              5.6 ± 0.9        5.9 ± 0.9        5.3 ± 1.0        NS
  Uric Acid, µmol/L              339.0 ± 71.4     410.4 ± 77.3     392.6 ± 59.5     NS
  Natrium, mmol/L                139 ± 3          140 ± 4          139 ± 3          NS
  Potassium, mmol/L              4.8 ± 1.1        4.9 ± 0.7        4.7 ± 1.3        NS
  Calcium, mmol/L                2.3 ± 0.2        2.3 ± 0.7        2.2 ± 2.0        NS
  Phosphorus, mmol/L             1.21 ± 0.22      1.22 ± 0.23      1.19 ± 0.20      NS
  Bicarbonates, mmol/L           20.81 ± 1.72     20.77 ± 1.77     20.85 ± 1.61     NS
  Cholesterol, mmol/L            3.99 ± 0.91      4.04 ± 0.85      3.94 ± 0.93      NS
  Triglycerides, mmol/L          1.51 ± 0.65      1.54 ± 0.7       1.48 ± 0.58      NS
  PTH, pmol/L                    12.94 ± 8.81     11.88 ± 7.43     14.43 ± 10.29    NS
  Haemoglobin, g/L               123 ± 17         124 ± 17         121 ± 18         NS
  Albumin, g/L                   39 ± 4           40 ± 5           38 ± 7           NS
  CRP, mg/L                      11 ± 28          10 ± 14          13 ± 35          NS
  Urinary natrium, mmol/day      144 ± 78         162 ± 77         135 ± 99         NS
  Urinary potassium, mmol/day    46 ± 24          52 ± 22          38 ± 19          NS
  Urinary phosphate, mmol/day    197.7 ± 86.9     201.2 ± 84.3     194.4 ± 73       NS
  UUN, mmol/day                  7.5 ± 2.5        7.1 ± 1.8        7.8 ± 2.1        NS
  Urinary proteins, g/day        0.525 ± 0.829    0.593 ± 1        0.424 ± 0.475    NS
  Urinary creatinine, µmol/day   87.5 ± 34.5      99 ± 32.7        69.8 ± 29.1      0.0001
  Creatinine clearance, mL/min   33 ± 15          39 ± 14          26 ± 12          0.0001
  Protein intake, g/day          78 ± 10          80 ± 12          75 ± 14          NS
  Phosphorus intake, mmol/day    329.5 ± 144.7    335.3 ± 140.5    324 ± 121.8      NS
  NEAP                           72 ± 36          73 ± 35          71 ± 37          NS
  PRAL                           23 ± 11          24 ± 13          22 ± 9           NS

BW: body weight; SBP: Systolic blood pressure; DBP: diastolic blood pressure; PTH: parathyroid hormone; CRP: C-reactive protein; UUN: urinary urea nitrogen; NEAP: net endogenous acid production; PRAL: potential renal acid load; NS: not significant.

nutrients-09-00069-t003_Table 3

###### 

Data at 6 and 12 months in control group and VLPD group.

                                 Control 6 Months   VLPD 6 Months    *p*      Control 12 Months   VLPD 12 Months   *p*
  ------------------------------ ------------------ ---------------- -------- ------------------- ---------------- --------
  BW, kg                         77.3 ± 13.7        70.2 ± 14.1      0.003    76.0 ± 13.0         69.1 ± 14.5      0.0001
  SBP, mmHg                      124 ± 17           115 ± 14         0.0001   128 ± 17            110 ± 16         0.0001
  DBP, mmHg                      76 ± 7             71 ± 8           0.0001   76 ± 9              70 ± 8           0.0001
  Creatinine, µmol/L             192.71 ± 66.3      194.48 ± 74.26   NS       196.25 ± 62.76      195.36 ± 71.6    NS
  Azotemia, mmol/L               31.06 ± 11.78      16.8 ± 8.6       0.0001   32.1 ± 11.1         14.6 ± 7.8       0.0001
  Glycaemia, mmol/L              6.5 ± 1.4          6.0 ± 1          NS       6.3 ± 1.2           6.2 ± 0.9        NS
  Uric acid, µmol/L              327.1 ± 118.9      315.2 ± 107.1    NS       285.5 ± 95.2        291.4 ± 29.7     NS
  Natrium, mmol/L                139 ± 4            139 ± 3          NS       140 ± 3             137 ± 3          NS
  Potassium, mmol/L              4.7 ± 0.5          5.3 ± 0.5        0.0001   4.8 ± 0.6           4.9 ± 0.5        NS
  Calcium, mmol/L                2.3 ± 0.1          2.1 ± 0.3        0.0001   2.3 ± 0.1           2.2 ± 0.2        0.0001
  Phosphate, mmol/L              1.4 ± 0.4          1.2 ± 0.2        0.0001   1.5 ± 0.4           1.1 ± 0.2        0.0001
  Bicarbonates, mmol/L           25.85 ± 1.90       26.81 ± 1.80     NS       25.71 ± 1.52        26.13 ± 1.66     NS
  Cholesterol, mmol/L            4.1 ± 0.8          3.9 ± 1          NS       4.4 ± 0.8           3.8 ± 0.8        NS
  Triglycerides, mmol/L          1.6 ± 0.8          1.5 ± 0.7        NS       1.4 ± 0.6           1.2 ± 0.5        NS
  PTH, pmol/L                    14.7 ± 15.9        12.2 ± 8.4       NS       22.4 ± 9.6          13.1 ± 8.7       0.0001
  Hb, g/L                        123 ± 15           116 ± 20         NS       123 ± 15            124 ± 10         NS
  Albumin, g/L                   38 ± 4             38 ± 5           NS       38 ± 4              38 ± 3           NS
  CRP, mg/L                      7 ± 10             6 ± 15           NS       6 ± 8               5 ± 10           NS
  Urinary natrium, mmol/day      142 ± 61           99 ± 36          0.0001   142 ± 58            95 ± 36          0.0001
  Urinary potassium, mmol/day    46 ± 18            31 ± 21          0.002    39 ± 13             47 ± 20          0.004
  Urinary phosphate, mmol/day    191.2 ± 76.9       112.7 ± 51.7     0.0001   76.9 ± 90.4         97.9 ± 61.4      0.0001
  UUN, mmol/day                  6.1 ± 1.8          2.9 ± 0.7        NS       6.4 ± 2.5           2.9 ± 1.1        0.0001
  Urinary proteins, g/day        0.429 ± 0.45       0.382 ± 0.42     NS       0.452 ± 0.661       0.211 ± 0.161    0.009
  Urinary creatinine, µmol/day   86.6 ± 30          81.3 ± 27.4      NS       88.4 ± 3.5          80.4 ± 25.6      NS
  Creatinine Clearance, mL/min   37 ± 15            28 ± 14          0.0001   35 ± 14             30 ± 17          NS
  Protein intake, g/day          77 ± 14            25 ± 7           0.0001   81 ± 16             30 ± 17          0.0011
  Phosphorus intake, mmol/day    318.8 ± 128.2      155.7 ± 86.2     0.0001   238.4 ± 93.7        117.5 ± 78.2     0.0001
  NEAP                           71 ± 39            33 ± 16          0.0001   77 ± 41             25 ± 11          0.0001
  PRAL                           22 ± 9             −4.5 ± 4.1       0.0001   34 ± 11             −13 ± 6          0.0001

BW: body weight; SBP: Systolic blood pressure; DBP: diastolic blood pressure; PTH: parathyroid hormone; CRP: C-reactive protein; UUN: urinary urea nitrogen. NS: not significant.

###### 

(**A**) PRAL (Potential Renal Acid Load) from −5 to −2.0 mEq/100 g; (**B**) PRAL (Potential Renal Acid Load) from −2.0 to 0 mEq/100 g; (**C**) PRAL (Potential Renal Acid Load) from 0 to 4.0 mEq/100 g; (**D**) PRAL (Potential Renal Acid Load) from 4.1 to 10 mEq/100 g; (**E**) PRAL (Potential Renal Acid Load) \> 10 mEq/100 g.

nutrients-09-00069-t004a_Table 4

###### 

**(A)** 

                     PRAL    K      P
  ------------------ ------- ------ -----
  **BEVERAGES**                     
  Apple juice        −2.2    101    5
  Beetroot juice     −3.9           
  Carrot juice       −4.8    292    42
  Espresso           −2.3    115    3
  Lemon juice        −2.5    140    10
  Orange juice       −2.9    200    17
  Red wine           −2.4    127    23
  Tomato juice       −2.8    188    19
  Vegetable          −3.6    193    17
  Apple vinegar      −2.3           8
  **VEGETABLE**                     
  Huzelnuts          −2.8    466    322
  Apples             −2.2    132    12
  Apricots           −4.8    320    16
  Bananas            −5.5    350    28
  Black currants     −6.5    370    43
  Cherries           −3.6    229    18
  Figs, dried        −18.1   1010   111
  Grapes             −3.9    192    4
  Kiwi               −4.1    400    34
  Lemon              −2.6    140    11
  Mango              −3.3    250    14
  Orange             −2.7    200    22
  Peache             −2.4    260    20
  Pear               −2.9    127    11
  Pineapple          −2.7    250    8
  Raisins            −21     275    29
  Strawberries       −2.2    160    28
  Watermelon         −1.9    280    25
  Broussel sprouts   −4.5    450    50
  Carrots            −4.9    220    37
  Cauliflower        −4.0    350    69
  Celery             −5.2    280    45
  Chicory            −2.0    180    31
  Eggplant           −3.4    184    33
  Fennel             −7.9    394    39
  Kale               −7.8    243    29
  Kohlrabi           −5.5    191    29
  Lamb's Lettuce     −5.0    459    30
  Lettuce            −2.5    240    31
  Potatoes           −4.0    570    54
  Radish, red        −3.7    240    75
  Ruccola            −7.5    468    52
  Sauerkraut         −3.0    170    20
  Soy beans          −3.4    485    142
  Spinach            −14.0   530    62
  Tomato             −3.1    297    26
  Zucchini           −4.6    264    65
  Brans, green       −3.1    566    734
  Parsley            −12.0   670    75
  Basil              −7.3    300    56
  Chives             −5.3    296    48
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**(B)** 

                                       PRAL   K      P
  ------------------------------------ ------ ------ -----
  **BEVERAGES**                                      
  Mineral water                        −0.1          
  Beer, draft                          −0.2   27     14
  Beer, stout                          −0.1   27     14
  White wine                           −1.2   71     74
  Cocoa, made with semi-skimmed milk   −0.4   169    105
  Coffee, infusion                     −1.4   30     3
  Fruit tea, infusion                  −0.3   19     36
  Grape juice                          −1.0   88     4
  Green tea, infusion                  −0.3   20     
  Herb tea                             −0.2   21     0
  Tea, Indian, infusion                −0.3          
  Wine vinegar                         −1.6   39     8
  **FAT and OIL**                                    
  Margarine                            −0.5   18     5
  Olive oil                            0.0    1      0
  Sunflower seed oil                   0.0    0      0
  **VEGETABLES**                                     
  Asparagus                            −0.4   172    65
  Broccoli, green                      −1.2   316    66
  Cucumber                             −0.8   140    17
  Garlic                               −1.7   401    153
  Gherkin, pickled                     −1.6          
  Leeks                                −1.8   180    35
  Lettuce, iceberg                     −1.6   141    20
  Mushrooms                            −1.6   318    86
  Onions                               −1.5   146    29
  Peppers, Capsicum, green             −1.4   1260   158
  Soy milk                             −0.8   143    
  Tofu                                 −0.8   151    52
  Whey                                 −1.6   143    78
  **SWEATS**                                         
  Honey                                −0.3   52     6
  Ice cream, fruit, mixed              −0.6   188    100
  Marmalade                            −1.5   77     19
  Nougat hazelnut cream                −1.4   407    152
  Sugar, brown                         −1.2   133    4
  Sugar, white                         0.0    2      
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**(C)** 

                                            PRAL   K     P
  ----------------------------------------- ------ ----- ------
  **BEVERAGES**                                          
  Coca cola                                 0.4    20    24.8
  **FAT and OIL**                                        
  Butter                                    0.6    15    16
  **VEGETABLE**                                          
  Lentils, green and brown, whole, dried    3.5    980   347
  Peas                                      1.2    990   320
  Buttermilk                                0.5    145   93
  Cream, fresh, sour                        1.2    119   66
  Curd cheese                               0.9    118   180
  Egg, white                                1.1    163   15
  Milk, whole, evaporated                   1.1    390   23.5
  Milk, whole, pasteurized and sterilized   0.7    132   84
  Skimmed milk                              0.7    156   84
  Yogurt, whole milk, fruit                 1.2    177   109
  Yogurt, whole milk, plain                 1.5    155   95
  **CEREALS, FLOUR and PASTA**                           
  Rice, white, boiled                       1.7    56    55
  Bread, wheat flour, whole meal            1.8    110   103
  Chocolate, bitter                         0.4    300   147
  Chocolate, milk                           2.4    420   208
  Ice cream, dairy vanilla                  0.6    199   105
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**(D)** 

                                 PRAL   K      P
  ------------------------------ ------ ------ -----
  **VEGETABLES**                               
  Peanuts, plain                 8.3    680    290
  Pistachio                      8.5    1025   490
  Sweet almond                   4.3    780    484
  Walnuts                        6.8    441    346
  **ANIMAL FOOD**                              
  Carp                           7.9    333    415
  Cod, fillets                   7.1    235    281
  Haddock                        6.8    286    227
  Halibut                        7.8    435    236
  Herring                        7.0    419    303
  Rose-fish                      10.0   269    200
  Salmon                         9.4    505    371
  Salted matie (herring)         8.0    447    325
  Shrimps                        7.6    89     282
  Sole                           7.4    160    252
  Zander                         7.1    269    200
  Beaf, lean only                7.8    349    211
  Cervelat sausage               8.9    260    190
  Chicken                        8.7    229    194
  Duck                           4.1    230    269
  Lamb, lean only                7.6    318    191
  Pork sausage                   7.0    260    192
  Rump steak, lean and fat       8.8    221    356
  Turkey, meat only              9.9    275    186
  Veal, fillet                   9.0    325    212
  Cottage cheese, plain          8.7           
  Egg, chicken, whole            8.2    138    198
  Full-fat soft cheese           4.3           
  **CEREALS, FLOUR and PASTA**                 
  Amaranth                       7.5    508    557
  Barely (whole meal)            5.0    75     40
  Bread, rye flour               4.1    166    125
  Bread, white wheat             3.7    110    103
  Buckwheat (whole grain)        3.7    460    330
  Coarse whole meal bread        5.3           
  Cornflakes                     6.0    73     49
  Crisp bread, rye               3.3    183    138
  Macaroni                       6.1    20     32
  Noodles                        6.4    22     20
  Pumpernickel                   4.2    208    178
  Rice, white                    4.6    75     96
  Rusk                           5.9    224    430
  Rye, flour                     4.4    510    332
  Spaetzle (German sort)         9.4    38     
  Spaghetti                      6.5    44     58
  Spaghetti, whole meal          7.3    44     89
  Wheat flour, whole meal        8.2    337    300
  Whole meal bread               7.2    248    202
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**(E)** 

                                 PRAL   K     P
  ------------------------------ ------ ----- -----
  **ANIMAL FOOD**                             
  Eel, smoked                    11,0   349   277
  Mussels                        15.3   268   236
  Prawn                          15.5   89    282
  Sardines in oil                13.5   397   490
  Tiger Prawn                    18.2   170   306
  Trout, steamed                 10.8   361   220
  Corned beef, canned            13.2   402   125
  Goose, lean only               13.0   388   309
  Liver (veal)                   14.2   308   350
  Luncheon meat, canned          15.4   564   109
  Ox liver fegato bue            15.4   320   350
  Pig's liver                    15.7   273   362
  Rabbit, lean only              19.0   383   180
  Salami                         11.6   452   225
  Camembert                      14.6   100   347
  Cheddar-type, reduced fat      26.4   120   545
  Edam cheese full fat           19.4   188   536
  Egg, yolk                      23.4   90    586
  Emmental cheese full fat       21.1   107   700
  Fresh cheese (Quark)           11.1   150   650
  Gouda                          18.6   121   443
  Hard cheese                    19.2   55    675
  Parmesan                       34.2   102   800
  Processed cheese, plain        28.7         943
  Rich cream full fat cheese     13.2   284   
  **CEREALS, FLOUR and PASTA**                
  Oat flakes                     10.7   429   523
  Rice, brown                    12.5   223   333

The green light indicates that food can be consumed every day, while the yellow light means a two or three times a week consumption, and the red light an occasional food consumption

[^1]: Aucella Filippo Piemontese Matteo, Grifa Rachele, SC di Nefrologia e Dialisi, IRCCS Casa Sollievo Della Sofferenza, 71013 San Giovanni Rotondo, Foggia, Italy; Guastaferro Pasquale, Nefrologia, Ospedale di Sant'Angelo dei Lombardi (Avellino), Italy; Vitale Fabio, Romano Giuseppina, Cozza Vincenzo, Nefrologia, Ospedale di Ariano Irpino (Avellino), Italy; Santoro Domenico, Annamaria Bruzzese, Francesca Montuori, Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy.
